Search research articles
Contact Us
Filters
Showing results (1001-1010 of 1,020) with videos related to
Page
of 102
Sort By:
Leukemia
|
July 1, 1996
Expression of costimulatory molecules in human leukemias
N Hirano, T Takahashi, T Takahashi, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 6, 2010
Cardioprotective effects of growth hormone-releasing hormone agonist after myocardial infarction
Rosemeire M Kanashiro-Takeuchi, Konstantinos Tziomalos, Lauro M Takeuchi, et al.
ESMO Open
|
May 7, 2025
Genome-wide DNA methylation status as a biomarker for clinical outcomes of first-line treatment in patients with RAS wild-type metastatic colorectal cancer: JACCRO CC-13AR
K Ouchi, Y Sunakawa, A Tsuji, et al.
The Review of Scientific Instruments
|
November 2, 2010
Application of beam emission spectroscopy to NBI plasmas of Heliotron J
S Kobayashi, S Kado, T Oishi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 19, 2015
A randomized phase II study of S-1 plus oral leucovorin versus S-1 monotherapy in patients with gemcitabine-refractory advanced pancreatic cancer
M Ueno, T Okusaka, Y Omuro, et al.
ESMO Open
|
September 13, 2023
Ramucirumab plus FOLFIRI as second-line treatment for patients with RAS wild-type metastatic colorectal cancer previously treated with anti-EGFR antibody: JACCRO CC-16
H Yasui, Y Okita, M Nakamura, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 29, 2011
Activation of growth hormone releasing hormone (GHRH) receptor stimulates cardiac reverse remodeling after myocardial infarction (MI)
Rosemeire M Kanashiro-Takeuchi, Lauro M Takeuchi, Ferenc G Rick, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 25, 2015
A randomized phase III trial of oral S-1 plus cisplatin versus docetaxel plus cisplatin in Japanese patients with advanced non-small-cell lung cancer: TCOG0701 CATS trial
K Kubota, H Sakai, N Katakami, et al.
Journal of the American College of Cardiology
|
June 1, 2019
Osteopontin Promotes Left Ventricular Diastolic Dysfunction Through a Mitochondrial Pathway
Keyvan Yousefi, Camila I Irion, Lauro M Takeuchi, et al.
ESMO Open
|
June 10, 2022
Dynamic changes in RAS gene status in circulating tumour DNA: a phase II trial of first-line FOLFOXIRI plus bevacizumab for RAS-mutant metastatic colorectal cancer (JACCRO CC-11)
Y Sunakawa, H Satake, J Usher, et al.
Page
of 102
Search research articles
Search
Showing results (1001-1010 of 1,020) with videos related to
Sort By:
Page
of 102
Leukemia
|
July 1, 1996
Expression of costimulatory molecules in human leukemias
N Hirano, T Takahashi, T Takahashi, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 6, 2010
Cardioprotective effects of growth hormone-releasing hormone agonist after myocardial infarction
Rosemeire M Kanashiro-Takeuchi, Konstantinos Tziomalos, Lauro M Takeuchi, et al.
ESMO Open
|
May 7, 2025
Genome-wide DNA methylation status as a biomarker for clinical outcomes of first-line treatment in patients with RAS wild-type metastatic colorectal cancer: JACCRO CC-13AR
K Ouchi, Y Sunakawa, A Tsuji, et al.
The Review of Scientific Instruments
|
November 2, 2010
Application of beam emission spectroscopy to NBI plasmas of Heliotron J
S Kobayashi, S Kado, T Oishi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 19, 2015
A randomized phase II study of S-1 plus oral leucovorin versus S-1 monotherapy in patients with gemcitabine-refractory advanced pancreatic cancer
M Ueno, T Okusaka, Y Omuro, et al.
ESMO Open
|
September 13, 2023
Ramucirumab plus FOLFIRI as second-line treatment for patients with RAS wild-type metastatic colorectal cancer previously treated with anti-EGFR antibody: JACCRO CC-16
H Yasui, Y Okita, M Nakamura, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 29, 2011
Activation of growth hormone releasing hormone (GHRH) receptor stimulates cardiac reverse remodeling after myocardial infarction (MI)
Rosemeire M Kanashiro-Takeuchi, Lauro M Takeuchi, Ferenc G Rick, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 25, 2015
A randomized phase III trial of oral S-1 plus cisplatin versus docetaxel plus cisplatin in Japanese patients with advanced non-small-cell lung cancer: TCOG0701 CATS trial
K Kubota, H Sakai, N Katakami, et al.
Journal of the American College of Cardiology
|
June 1, 2019
Osteopontin Promotes Left Ventricular Diastolic Dysfunction Through a Mitochondrial Pathway
Keyvan Yousefi, Camila I Irion, Lauro M Takeuchi, et al.
ESMO Open
|
June 10, 2022
Dynamic changes in RAS gene status in circulating tumour DNA: a phase II trial of first-line FOLFOXIRI plus bevacizumab for RAS-mutant metastatic colorectal cancer (JACCRO CC-11)
Y Sunakawa, H Satake, J Usher, et al.
Page
of 102